413 studies found for:    (human papillomavirus OR hpv) AND (woman OR women OR female)
Show Display Options
Rank Status Study
21 Active, not recruiting A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
Condition: Human Papillomavirus Infection
Intervention: Biological: V503 (9-valent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) vaccine)
22 Enrolling by invitation Evaluate the Safety of Recombinant Human Papillomavirus Bivalent (Types 16 and 18) Vaccine (Yeast) in Healthy Females
Condition: Human Papillomavirus
Interventions: Biological: HPV 16/18 vaccine, 0,5ml;   Biological: Placebo control, 0.5ml;   Biological: HPV 16/18 vaccine, 1.0ml;   Biological: Placebo control, 1.0ml
23 Completed
Has Results
Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine
Condition: Infections, Papillomavirus
Interventions: Biological: CervarixTM;   Biological: HPV investigational vaccine GSK568893A, different formulations
24 Active, not recruiting Vaginal Self-sampling and Human Papillomavirus Testing in Unscreened Women
Condition: Cancer Cervix
Interventions: Behavioral: Group 1 remove self sample kit at gp consulting room or perform pap smear;   Behavioral: Group 2 perform self sample at home or pap smear
25 Completed
Has Results
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
Conditions: HIV Infections;   Sexually Transmitted Diseases
Intervention: Biological: Quadrivalent HPV vaccine
26 Completed
Has Results
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)
Conditions: Genital Warts;   Anal Cancer;   Anal Intraepithelial Neoplasia
Intervention: Biological: 9vHPV Vaccine
27 Completed Epidemiology of Papillomavirus Infection (HPV) on Infected Women by Human Immunodeficience Virus (HIV) in West Indies and French Guiana.
Conditions: 1- Women;   2- HIV Infection;   3- Followed in West Indies and French Guiana for His Infection;   4- Acceptance of the Use of Nadis® Medical Files
Intervention: Other: Biological Sample collection
28 Completed The Human Papillomavirus (HPV) Transmission Pilot Study
Condition: Human Papillomavirus Infection
Intervention:
29 Recruiting Video to Promote HPV Vaccination
Conditions: Vaccine Acceptance;   Social Acceptance;   Acceptance Processes;   Health Behavior;   Human Papillomavirus
Intervention: Other: Educational Video with Male or Female Narrator
30 Completed Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix TM) Administered in Healthy Adolescents
Condition: Infections, Papillomavirus
Interventions: Biological: GSK Biologicals' HPV Vaccine GSK580299;   Biological: Engerix-B™
31 Active, not recruiting HPV Testing for Cervical Cancer Screening Study
Condition: Cervical Cancer Screening
Intervention: Procedure: Cervical cancer screening undertaken by HPV testing as a single primary screening test with cytology triage of women who are HPV positive
32 Completed
Has Results
Immunogenicity and Safety of GSK Biologicals' HPV Vaccine 580299 in Healthy Japanese Females 10-15 Years of Age
Condition: Papillomavirus Vaccines
Intervention: Biological: Cervarix™ (HPV-16/18 L1 VLP AS04)
33 Completed
Has Results
Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease
Conditions: Inflammatory Bowel Disease;   Uterine Cervical Dysplasia
Intervention: Biological: Human Papillomavirus Vaccine
34 Completed
Has Results
Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age
Condition: HPV-16/18 Infections and Cervical Neoplasia
Intervention: Biological: Cervarix TM
35 Completed A Study to Examine the Human Papillomavirus Types Exposure in Women From Southern Africa and Brasil
Conditions: HIV;   HIV Infections
Intervention:
36 Completed
Has Results
Follow-up Study to Evaluate the Long-term Efficacy of the HPV Vaccine (580299) in Healthy Young Adult Women in Brazil
Conditions: HPV-16/18 Infections;   Cervical Neoplasia
Interventions: Procedure: Blood sampling;   Procedure: Collection of cervical specimen
37 Completed
Has Results
Vaccine Therapy in Preventing HPV in HIV-Positive Women in India
Conditions: Cervical Cancer;   Nonneoplastic Condition;   Precancerous Condition
Interventions: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine;   Genetic: DNA analysis;   Genetic: polymerase chain reaction;   Other: cytology specimen collection procedure;   Procedure: colposcopic biopsy
38 Completed
Has Results
Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine 580299 in Healthy Females 10 - 25 Years of Age.
Conditions: HPV-16/18 Infections;   Cervical Neoplasia
Interventions: Biological: CervarixTM;   Biological: Placebo vaccine (Al(OH)3)
39 Active, not recruiting
Has Results
Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)
Conditions: Cervical Cancer;   Vulvar Cancer;   Vaginal Cancer;   Genital Warts;   Human Papillomavirus Infection
Interventions: Biological: Comparator: GARDASIL;   Biological: Experimental: V503
40 Completed
Has Results
Evaluation of the Immune and Safety Response of GlaxoSmithKline (GSK) Biologicals' HPV Vaccine in Healthy Indian Women
Conditions: Cervical Cancer;   Papillomavirus Infection
Interventions: Biological: Placebo;   Biological: HPV-16/18 VLP/AS04 Vaccine (Cervarix TM)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years